¡Su carro está actualmente vacío!
£261.25
£261.25
The Cardiometabolic Serum Test is more advanced than a standard screen for cardiovascular disease (CVD) risk factors. The test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC). PLAC activity is a sensitive indicator of active atherogenesis and instability of advanced arterial plaque. The test also includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark®) that is a better indicator of hyperglycaemic episodes than HbA1C. The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed. This test is useful for those with a family or personal history, excess abdominal fat, obesity, insulin resistance and fatty liver disease. It can also be used for preventative purposes in asymptomatic patients.
The Cardiometabolic Serum Test is more advanced than a standard screen for cardiovascular disease (CVD) risk factors. The test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC). PLAC activity is a sensitive indicator of active atherogenesis and instability of advanced arterial plaque. The test also includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark®) that is a better indicator of hyperglycaemic episodes than HbA1C. The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed. This test is useful for those with a family or personal history, excess abdominal fat, obesity, insulin resistance and fatty liver disease. It can also be used for preventative purposes in asymptomatic patients.